The Southern Medical Journal (SMJ) is the official, peer-reviewed journal of the Southern Medical Association. It has a multidisciplinary and inter-professional focus that covers a broad range of topics relevant to physicians and other healthcare specialists.

SMJ // Article

Review Article

The Adverse Effects of Artri King: A Systematic Review and Case Series

Authors: Magnus Chun, MD, Jenna Sutton, DO, Jessica Chung, DO, Jose Lazarte, MD, Anna Horvath, BS, Madison Elmer, BS, Hazem Aboaid, MD, Badrunnisa Hanif, MD

Abstract

There has been an uptrend in patients taking Artri King, an over-the-counter supplement marketed for joint pain despite Food and Drug Administration warnings of it containing undeclared substances such as diclofenac and dexamethasone. Despite the popularity of this supplement, there is a lack of awareness of the deleterious, adverse effects. To our knowledge, there has not been a systematic review evaluating outcomes of patients taking Artri King. A comprehensive literature search was performed from major databases from inception to June 17, 2024, including case studies or case series investigating outcomes of patients taking Artri King as a supplement or treatment. A total of 16 patients (12 female and 4 male) from 10 studies were included in our literature review, with four of those patients being from our home institution. Patients presented with a wide variety of chief complaints, but fragility fractures were the most common at our home institution. The average duration of Artri King use was 16.67 months (at our home institution) versus 13.35 months for the rest. Overall, 75% of the patients included were diagnosed as having Cushing syndrome. Serious adverse effects of taking Artri King include Cushing syndrome, adrenal insufficiency, and worsening hyperglycemia. Clinicians should obtain a thorough drug and supplement history, and we recommend informing patients of the serious adverse effects associated with Artri King and advise against its use.

 

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Mishra S, Stierman B, Gahche JJ, et al. Dietary supplement use among adults: United States, 2017-2018. NCHS Data Brief 2021;(399):1–8.
 
2. US Food and Drug Administration, Center for Drug Evaluation and Research. FDA warns consumers not to purchase or use Artri and Ortiga products. www.fda.gov/drugs/drug-safety-and-availability/fda-warns-consumers-not-purchase-or-use-artri-andortiga-products-which-may-contain-hidden-drug. Published October 8, 2023. Accessed August 7, 2024.
 
3. Pena RH, Herrera R, Earns A, et al. #1706019 Cushing’s syndrome from unrecognized glucocorticoid use [abstract]. Endocr Pract 2024;30:S15.
 
4. Dani A, Ede K, Price H, et al. Cushingoid clinical features in a pediatric patient taking a natural supplement: buyer beware. JAAD Case Rep 2023;41:68-70.
 
5. Patel R, Sherf S, Lai NB, et al. Exogenous Cushing syndrome caused by a “herbal” supplement. AACE Clin Case Rep 2022;8:239–242.
 
6. Morales T, Samarasinghe S. FRI365 A patient with a bronchial carcinoid presents with cushingoid symptoms due to a potentially dangerous supplement. J Endocr Soc 2023;7(Suppl 1):bvad114.1297.
 
7. Maraqa S, Bushnaq L, Singh R, et al. SAT328 severe exogenous Cushing syndrome caused by a potent steroid concealed in arthritis supplement. J Endocr Soc 2023;7(Suppl 1): bvad114.332.
 
8. Dunn C, Amaya J, Green P. A case of iatrogenic Cushing’s syndrome following use of an over-the-counter arthritis supplement. Case Rep Endocrinol 2023;2023:4769258.
 
9. Boncompagni AC, Ruiz E, Rider AC. A case of iatrogenic Cushing syndrome and subsequent adrenal insufficiency from a hidden ingredient in the supplement Artri Ajo King. J Am Coll Emerg Physicians Open 2023;4:e13007.
 
10. Saad-omer SM, Kinaan M, Matos M, et al. Exogenous Cushing syndrome and hip fracture due to over-the-counter supplement (Artri King). Cureus 2023;15:e41278.
 
11. Berg EA, Dao L, Yu R, et al. Artri King-induced hypothalamic-pituitary-adrenal axis disruption: a report of 3 cases. JCEM Case Rep 2023;2:luad154.
 
12. National Institute of Diabetes and Digestive and Kidney Diseases, US Department of Health and Human Services. Cushing’s syndrome. https://www.niddk.nih.gov/health-information/endocrine-diseases/cushings-syndrome. Accessed August 7, 2024.
 
13. PRISMA. Homepage. https://www.prisma-statement.org/. Accessed May 5, 2025.
 
14. National Heart, Lung, and Blood Institute. Study quality assessment tools. https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools. Accessed May 5, 2025.
 
15. Karagas MR, Lu-Yao GL, Barrett JA, et al. Heterogeneity of hip fracture: age, race, sex, and geographic patterns of femoral neck and trochanteric fractures among the US elderly. Am J Epidemiol 1996;143:677–682.
 
16. Tucker ME. Over-the-counter arthritis supplements pose adrenal danger https://www.medscape.com/viewarticle/over-counter-arthritis-supplements-pose-adrenal-danger-2024a1000amy. Published June 6, 2024. Accessed May 5, 2025.
 
17. Australian Government, Department of Health and Aged Care, Therapeutic Goods Administration. Artri King tablets. https://www.tga.gov.au/news/safety-alerts/artri-king-tablets. Published January 31, 2024. Accessed May 5, 2025.